Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 359

1.

NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, Przedborski S.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):6145-50. Epub 2003 Apr 29.

2.

Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.

Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, Zhang W, Hong JS, Liu B.

FASEB J. 2004 Mar;18(3):589-91. Epub 2004 Jan 20.

PMID:
14734632
3.
4.

Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease.

Gao HM, Liu B, Zhang W, Hong JS.

FASEB J. 2003 Oct;17(13):1954-6. Epub 2003 Aug 1.

PMID:
12897068
5.

Prothrombin kringle-2-induced oxidative stress contributes to the death of cortical neurons in vivo and in vitro: role of microglial NADPH oxidase.

Won SY, Choi SH, Jin BK.

J Neuroimmunol. 2009 Sep 29;214(1-2):83-92. doi: 10.1016/j.jneuroim.2009.07.005. Epub 2009 Aug 5.

PMID:
19660816
6.

Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.

Shin JY, Park HJ, Ahn YH, Lee PH.

J Neurochem. 2009 Nov;111(4):1042-50. doi: 10.1111/j.1471-4159.2009.06381.x. Epub 2009 Sep 16.

7.
8.

Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.

Zhang D, Hu X, Wei SJ, Liu J, Gao H, Qian L, Wilson B, Liu G, Hong JS.

J Neuroinflammation. 2008 May 28;5:21. doi: 10.1186/1742-2094-5-21.

9.

Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not.

Kreisler A, Gelé P, Wiart JF, Lhermitte M, Destée A, Bordet R.

Brain Res. 2007 Mar 2;1135(1):77-84. Epub 2007 Jan 2.

PMID:
17196944
10.

Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Kohutnicka M, Lewandowska E, Kurkowska-Jastrzebska I, Członkowski A, Członkowska A.

Immunopharmacology. 1998 Jun;39(3):167-80.

PMID:
9754903
11.

A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism.

Mandir AS, Simbulan-Rosenthal CM, Poitras MF, Lumpkin JR, Dawson VL, Smulson ME, Dawson TM.

J Neurochem. 2002 Oct;83(1):186-92.

12.

Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Przedborski S, Chen Q, Vila M, Giasson BI, Djaldatti R, Vukosavic S, Souza JM, Jackson-Lewis V, Lee VM, Ischiropoulos H.

J Neurochem. 2001 Jan;76(2):637-40.

13.
14.

Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.

Rojo AI, Innamorato NG, Martín-Moreno AM, De Ceballos ML, Yamamoto M, Cuadrado A.

Glia. 2010 Apr;58(5):588-98. doi: 10.1002/glia.20947.

PMID:
19908287
15.

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S.

J Neurosci. 2002 Mar 1;22(5):1763-71.

17.

Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.

Barcia C, Sánchez Bahillo A, Fernández-Villalba E, Bautista V, Poza Y Poza M, Fernández-Barreiro A, Hirsch EC, Herrero MT.

Glia. 2004 May;46(4):402-9.

PMID:
15095370
18.

Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.

Anderson DW, Bradbury KA, Schneider JS.

Eur J Neurosci. 2008 Aug;28(3):610-7. doi: 10.1111/j.1460-9568.2008.06356.x.

PMID:
18702732
19.

Fucoidan protects against dopaminergic neuron death in vivo and in vitro.

Luo D, Zhang Q, Wang H, Cui Y, Sun Z, Yang J, Zheng Y, Jia J, Yu F, Wang X, Wang X.

Eur J Pharmacol. 2009 Sep 1;617(1-3):33-40. doi: 10.1016/j.ejphar.2009.06.015. Epub 2009 Jun 21.

PMID:
19545563
20.

Supplemental Content

Support Center